LogiPharma Europe 2023: Wayne Rothman Discusses Problematic Supply Chain Scenarios

The investment not only moves along the company’s efforts in advancing clinical studies, but also opens up 700 new jobs for the Greater Toronto area.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

The license agreement will feature an upcoming Phase III trial and—depending on results—the development, manufacturing, and commercialization of evenamide as a potential treatment option.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

The Drug Supply Chain Security Act was a major coverage area for Pharma Commerce in 2024.

Jon Hamrick, partner, Curatio Scientia Advisors, discusses upcoming industry challenges at this year's Trade & Channel Strategies Conference in Philadelphia.